PALO ALTO, Calif.--(BUSINESS WIRE)--Connetics Corporation (Nasdaq:CNCT), a specialty pharmaceutical company that develops and commercializes dermatology products, today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, in connection with the proposed merger of Connetics with Stiefel Laboratories, Inc.
